國立虎尾科技大學 |

Biomarkers in Inflammatory Bowel Diseases

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Biomarkers in Inflammatory Bowel Diseases/ edited by Nik Sheng Ding, Peter De Cruz.
other author:	Sheng Ding, Nik.
Description:	XVII, 365 p. 35 illus., 30 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Gastroenterology . -
Online resource:	https://doi.org/10.1007/978-3-030-11446-6
ISBN:	9783030114466

Biomarkers in Inflammatory Bowel Diseases
Biomarkers in Inflammatory Bowel Diseases[electronic resource] /edited by Nik Sheng Ding, Peter De Cruz. - 1st ed. 2019. - XVII, 365 p. 35 illus., 30 illus. in color.online resource.

Part I: Introduction -- nflammatory bowel disease – more than meets the eye - Clinical risk factors – lessons from epidemiology -- Clinical trial design for biomarker discovery -- Database/ big data meets real world -- Patient reported outcomes -- Part II: Biomarkers – Prognostic vs Predictive -- Biomarkers for remote monitoring -- Disease modification -- Part IIV: Crohn’s disease -- Luminal Crohn’s disease-. Perianal CD -- Fibrosis/ strictures in CD -- Post-op Crohn’s disease -- Part IV: Ulcerative colitis -- UC surveillance -- Acute severe UC -- Chronic active UC -- Pouchitis -- Refractory proctitis -- Feacal microbiota transplantation -- Primary sclerosing cholangitis -- Extraintestinal manifestations of IBD -- Part V: Specialised scenarios -- Pregnancy -- Nutrition -- TDM -- Biomarkers to quantify immune response -- Drug toxicity -- Part VI:Scientific -- Exposome and diet -- Microbiota -- Metabonomics -- Immunology -- Genomics -- Systems Biology in Biomarker research -- Part VII: Ideal tools for investigation in the future.

This book provides a comprehensive and complete overview of biomarkers in clinical practice for inflammatory bowel disease (IBD) bringing together the literature in a clear and concise manner. The book bridges the gap between growing knowledge at the bench and current and future applications of biomarkers in clinical practice. The central structure of the book focuses on prognostic and predictive biomarkers in IBD with an emphasis on the fields of research and scientific techniques (genomics, proteomics and metabonomics) that have led to biomarker discovery and places these biomarkers within a clinical context to help understand their utility in clinical practice. This book will be of use to clinicians who have an interest in using biomarkers in clinical practice as well as clinician researchers and scientists involved in the biomarker research pipeline. The author team comprises experts from around the world in order to bring together the literature in an effort to inform clinicians and researchers about the current state-of-the art in biomarker discovery. It is intended to assist future research efforts and indicate how biomarkers might be best applied to clinical practice both at present and in the future.

ISBN: 9783030114466

Standard No.: 10.1007/978-3-030-11446-6doiSubjects--Topical Terms:

1254565
Gastroenterology .

LC Class. No.: RC799-869

Dewey Class. No.: 616.33

Biomarkers in Inflammatory Bowel Diseases
LDR:03572nam a22003855i 4500 001 1005088
003 DE-He213
005 20200706080912.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030114466 $9 978-3-030-11446-6
024 7 $a 10.1007/978-3-030-11446-6 $2 doi
035 $a 978-3-030-11446-6
050 4 $a RC799-869
072 7 $a MJH $2 bicssc
072 7 $a MED031000 $2 bisacsh
072 7 $a MJH $2 thema
082 0 4 $a 616.33 $2 23
245 1 0 $a Biomarkers in Inflammatory Bowel Diseases $h [electronic resource] / $c edited by Nik Sheng Ding, Peter De Cruz.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a XVII, 365 p. 35 illus., 30 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Part I: Introduction -- nflammatory bowel disease – more than meets the eye - Clinical risk factors – lessons from epidemiology -- Clinical trial design for biomarker discovery -- Database/ big data meets real world -- Patient reported outcomes -- Part II: Biomarkers – Prognostic vs Predictive -- Biomarkers for remote monitoring -- Disease modification -- Part IIV: Crohn’s disease -- Luminal Crohn’s disease-. Perianal CD -- Fibrosis/ strictures in CD -- Post-op Crohn’s disease -- Part IV: Ulcerative colitis -- UC surveillance -- Acute severe UC -- Chronic active UC -- Pouchitis -- Refractory proctitis -- Feacal microbiota transplantation -- Primary sclerosing cholangitis -- Extraintestinal manifestations of IBD -- Part V: Specialised scenarios -- Pregnancy -- Nutrition -- TDM -- Biomarkers to quantify immune response -- Drug toxicity -- Part VI:Scientific -- Exposome and diet -- Microbiota -- Metabonomics -- Immunology -- Genomics -- Systems Biology in Biomarker research -- Part VII: Ideal tools for investigation in the future.
520 $a This book provides a comprehensive and complete overview of biomarkers in clinical practice for inflammatory bowel disease (IBD) bringing together the literature in a clear and concise manner. The book bridges the gap between growing knowledge at the bench and current and future applications of biomarkers in clinical practice. The central structure of the book focuses on prognostic and predictive biomarkers in IBD with an emphasis on the fields of research and scientific techniques (genomics, proteomics and metabonomics) that have led to biomarker discovery and places these biomarkers within a clinical context to help understand their utility in clinical practice. This book will be of use to clinicians who have an interest in using biomarkers in clinical practice as well as clinician researchers and scientists involved in the biomarker research pipeline. The author team comprises experts from around the world in order to bring together the literature in an effort to inform clinicians and researchers about the current state-of-the art in biomarker discovery. It is intended to assist future research efforts and indicate how biomarkers might be best applied to clinical practice both at present and in the future.
650 0 $a Gastroenterology . $3 1254565
650 0 $a Microbial genetics. $3 582864
650 0 $a Microbial genomics. $3 782637
650 0 $a Proteomics. $3 581930
650 1 4 $a Gastroenterology. $3 673684
650 2 4 $a Microbial Genetics and Genomics. $3 668641
700 1 $a Sheng Ding, Nik. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1227490
700 1 $a De Cruz, Peter. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1227491
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030114459
776 0 8 $i Printed edition: $z 9783030114473
856 4 0 $u https://doi.org/10.1007/978-3-030-11446-6
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)